Pure Arctic Cod Liver Oil Natural Strawberry Flavor

Pure Arctic Cod Liver Oil Natural Strawberry Flavor

ChildLife Essentials4.7 (8,390 ratings)
Format:Liquid Quantity: 8 Fluid Ounce(s) · 24 servings
Goals

Product analysis

52 out of 100

Pure Arctic Cod Liver Oil Natural Strawberry Flavor provides omega-3 fatty acids that may modestly support joint comfort, with appealing value for the fatty acids provided.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality21

The omega-3 forms are unspecified, limiting comparison of absorption. The quality of the other listed components also remains uncertain.

Ingredient Transparency44

Several amounts are stated, but some are missing and most forms are unspecified. Composition details are also incomplete, preventing a full comparison of the oil.

Value For Money84

The omega-3 contribution is economical, with good value for EPA and DHA individually. Value for saturated fat remains uncertain.

Customer Satisfaction90

Customer ratings are very positive across thousands of reviews. That provides a broad view of satisfaction without proving health benefits.

Product Focus42

Omega-3 fatty acids may provide modest joint-comfort support, though findings vary and often involve higher repeated intake. Broader skin and metabolism benefits remain uncertain for this preparation.

Format
Liquid
Container
8 Fluid Ounce(s)
Per serving
$0.73
Customer rating
4.7 · 8,390 ratings
Report analysis

Goals

Impact
Limited evidence
F Ingredient FitF PathwaysF EvidenceF Formulation Logic
EPA (Eicosapentaenoic Acid) · 800 mgVitamin D · 20 mcg
Study evidence
Vitamin D Mixed 164 studies
Skin Health
Impact
High effect
C+ Ingredient FitD- PathwaysB EvidenceA+ Formulation Logic
Vitamin E · 10 mgOmega-3 · 450 mg
Study evidence
Omega-3 Supportive 35 studies
Vitamin A Supportive 106 studies
Vitamin E Supportive 38 studies
Joint Health
Impact
Lower effect
D- Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Omega-3 · 450 mg
Study evidence
Omega-3 Supportive 40 studies
Vitamin D Supportive 111 studies
Metabolism Support
Impact
Moderate effect
F Ingredient FitF PathwaysA- EvidenceA+ Formulation Logic
Omega-3 · 450 mgVitamin D · 20 mcg
Study evidence
Omega-3 Supportive 42 studies
Vitamin D Supportive 65 studies
Mental Focus
Impact
Lower effect
D Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Vitamin D · 20 mcg
Study evidence

Ingredients

IngredientAmount per servingScore
Calories
85 Calorie(s)
Total Fat
9 Gram(s)
Saturated Fat
1.5 Gram(s)
Cholesterol
45 mg
Vitamin A (Cod Liver Oil, Retinyl Palmitate)
500 mcg
Vitamin D (Cholecalciferol, Vitamin D3)
20 mcg
Vitamin E (D-Alpha-Tocopherol)
10 mg
Total Omega-3 Fatty Acids
2350 mg 53
Docosahexaenoic Acid
1100 mg 62
Eicosapentaenoic Acid
800 mg 62
Other Omega-3 Fatty Acids
450 mg 53
Gluten Free Dairy Free Children 4+ Children 1–4 Infants 0–1
Report overview
D+ Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyB+ Value
800 mg EPA per serving comes at a moderate cost per gram of EPA. The molecular form is unspecified.
How this ingredient is rated

Active Ingredient Quality & Bioavailability50

The EPA molecular form is unspecified. EPA makes up about 34.0% of the total omega-3.
Molecular Form and Bioavailability
The EPA molecular form is unspecified.
EPA Concentration Density
EPA makes up about 34.0% of the total omega-3.
Oxidation Protection
Tocopherol is included as an antioxidant.

Dose, Safety & Label Transparency65

The serving has 800 mg EPA and 1100 mg DHA. Purification is indicated, but third-party contaminant testing is not established.
Absolute EPA Dose per Serving
Each serving provides 800 mg EPA.
EPA-Centric Ratio
The serving has 800 mg EPA and 1100 mg DHA.
Purity and Contaminant Testing
Purification is indicated, but third-party contaminant testing is not established.

Value80

The cost per gram of EPA is moderate.
Price per Gram of EPA
The cost per gram of EPA is moderate.
Omega-3 · 2350 mg OverallScore53
D- Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyA+ Value
The serving lists 800 mg EPA and 1100 mg DHA. The cost per gram of combined EPA and DHA is low. The molecular form of the omega-3s is not specified. The oil amount is unavailable, leaving concentration unclear.
How this ingredient is rated

Active Ingredient Quality & Bioavailability40

The molecular form of the omega-3s is not specified. The formula lists 10 mg vitamin E.
Molecular Form & Absorption Potential
The molecular form of the omega-3s is not specified.
Source Purity & Oxidative Protection
An oil source is noted. The formula lists 10 mg vitamin E.

Dose, Safety & Label Transparency43

The serving lists 800 mg EPA and 1100 mg DHA. The oil amount is unavailable, so concentration is unknown.
EPA & DHA Label Specificity
The serving lists 800 mg EPA and 1100 mg DHA.
Active Ingredient Concentration
The oil amount is unavailable, so the EPA and DHA concentration is unknown.
Third-Party Purity Verification
Testing is mentioned, but a qualifying certification or accessible certificate of analysis is not noted.

Value100

The cost per gram of combined EPA and DHA is low.
Price per 1000mg of EPA+DHA
The cost per gram of combined EPA and DHA is low.
DHA · 1100 mg OverallScore62
D- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyB+ Value
It provides 1100 mg of DHA per serving at a fairly low cost per amount of DHA. Its chemical form is unclear. The oil is described as molecularly distilled.
How this ingredient is rated

Active Ingredient Quality & Bioavailability42

The DHA chemical form is unclear. An antioxidant is included.
DHA Chemical Form & Bioavailability
The DHA chemical form is not specified.
Oxidation Protection & Stability
An antioxidant is included for protection.
Oil Concentration & Purity
The omega-3 concentration is unclear because the necessary total omega-3 or oil amount is unavailable.

Dose, Safety & Label Transparency74

Each serving provides 1100 mg of DHA. The source is cod liver oil.
DHA Absolute Dosage
Each serving provides 1100 mg of DHA.
Purity & Heavy Metal Verification
The oil is described as molecularly distilled.
Ingredient Source Transparency
The source is cod liver oil.

Value80

The cost per amount of DHA is fairly low.
Price per Gram of DHA
The cost per amount of DHA is fairly low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  3. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  5. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  6. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
    Yin WJ; Wang P; Ma SS; Tao RX; Hu HL; Jiang XM; Zhang Y; Tao FB; Zhu P · European journal of nutrition · 2024
    Randomized trial1,537 participantsHeart Health forVitamin D
  7. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsHeart Health forVitamin D
  8. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Mirhosseini N; Rainsbury J; Kimball SM · Frontiers in cardiovascular medicine · 2020
    Meta-analysis81 studies pooledHeart Health forVitamin D
  9. Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
    Abumweis S; Alqadi S; Al Tarteer A; Alrefai W; Alzoughool F; Jew S; Qudah T · Asia Pacific journal of clinical nutrition · 2026
    Meta-analysis45 studies pooledHeart Health forVitamin D
  10. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisHeart Health forVitamin D
  11. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  12. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  13. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  14. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  15. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  16. Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis.
    Wang X; Cicuttini F; Jin X; Wluka AE; Han W; Zhu Z; Blizzard L; Antony B; Winzenberg T; Jones G; Ding C · Osteoarthritis and cartilage · 2018
    Randomized trial413 participantsJoint Health forVitamin D
  17. Vitamin D Deficiency Leads to Poorer Health Outcomes and Greater Length of Stay After Total Knee Arthroplasty and Supplementation Improves Outcomes: A Systematic Review and Meta-Analysis.
    Vivek K; Kamal R; Perera E; Gupte CM · JBJS reviews · 2024
    Meta-analysis146,054 participants10 studies pooledJoint Health forVitamin D
  18. Does vitamin D improve symptomatic and structural outcomes in knee osteoarthritis? A systematic review and meta-analysis.
    Zhao ZX; He Y; Peng LH; Luo X; Liu M; He CS; Chen J · Aging clinical and experimental research · 2021
    Meta-analysis1,599 participants6 studies pooledJoint Health forVitamin D
  19. Baseline 25-hydroxyvitamin D levels predict the effects of vitamin D supplementation on joint symptoms and cartilage loss in patients with knee osteoarthritis.
    Wang T; Zheng S; Jin X; Cen H; Zhu Z; Han W; Wluka A; Cicuttini F; Cao P; Ding C · Rheumatology advances in practice · 2025
    Randomized trial413 participantsJoint Health forVitamin D
  20. The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis.
    Yang W; Sun C; He SQ; Chen JY; Wang Y; Zhuo Q · Journal of general internal medicine · 2021
    Meta-analysis11,890 participants28 studies pooledJoint Health forVitamin D